Bharat Biotech begins clinical trials of TB vaccine 'MTBVAC' on adults in India

Mar 24, 2024

As per Bharat Biotech, MTBVAC is the first vaccine against Tuberculosis derived from a human source by the Spanish biopharmaceutical company, Biofabri.